Budesonide Inhalation Suspension
Product Images NDC 68180-984

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Budesonide Inhalation (NDC 68180-984). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

E986c849 75fc 4c78 B593 1bd0c878adf8 01

Chemical structure diagram of budesonide, the active ingredient in budesonide inhalation suspension. The image shows the molecular arrangement and chemical bonds characteristic of budesonide.*

FDA Label Image

E986c849 75fc 4c78 B593 1bd0c878adf8 02

A line graph titled 'Nighttime Asthma Change from Baseline' depicting mean change in nighttime asthma symptoms over 12 weeks. The x-axis shows time points from baseline through week 12, and the y-axis shows mean change from baseline ranging from 0.0 to -0.6. Four lines represent different treatment groups: placebo, 0.25 mg once daily, 0.5 mg once daily, and 1.0 mg once daily, showing symptom improvements compared to placebo. P-values for statistical significance are noted for each dosage below the graph.*

FDA Label Image

E986c849 75fc 4c78 B593 1bd0c878adf8 03

Line graph illustrating the mean change from baseline in nighttime asthma symptoms over 12 weeks comparing placebo, 0.25 mg twice daily, and 0.5 mg twice daily dosing. The x-axis represents time in weeks and the y-axis depicts the mean change values. The graph includes p-values for 0.25 mg and 0.5 mg doses.*

FDA Label Image

E986c849 75fc 4c78 B593 1bd0c878adf8 04

A line graph titled 'Nighttime Asthma Change from Baseline' showing mean changes in nighttime asthma symptoms over a 12-week period for different budesonide inhalation dosages and placebo. The x-axis represents time intervals from baseline to week 12, and the y-axis shows mean change from baseline. Five lines compare placebo, 0.25 mg once daily, 0.25 mg twice daily, 0.5 mg twice daily, and 1.0 mg once daily, with p-values indicating statistical significance for each treatment group.*

FDA Label Image

E986c849 75fc 4c78 B593 1bd0c878adf8 05

An instructional line drawing showing hands opening a blister pack, likely demonstrating how to access individual doses of medication. The illustration emphasizes proper handling of a sealed unit dose container designed for inhalation suspension.*

FDA Label Image

E986c849 75fc 4c78 B593 1bd0c878adf8 06

An instructional illustration showing a hand holding a small inhalation suspension vial. Below the vial, there is a curved arrow indicating a twisting action, suggesting the vial should be twisted to open or prepare for use.*

FDA Label Image

E986c849 75fc 4c78 B593 1bd0c878adf8 07

An instructional illustration showing a person holding an ampule with one hand and using the other hand to snap off the ampule top by applying a twisting motion, indicated by a curved arrow around the neck of the ampule.*

FDA Label Image

E986c849 75fc 4c78 B593 1bd0c878adf8 08

An instructional black and white line drawing showing a person preparing a respiratory inhalation device by inserting or shaking a suspension vial into the inhaler container, demonstrating proper handling of budesonide inhalation suspension for respiratory use.*

FDA Label Image

E986c849 75fc 4c78 B593 1bd0c878adf8 09

Label for Budesonide Inhalation Suspension 0.5 mg/2 mL by Lupin Pharmaceuticals, Inc. The label states it is for inhalation only, supplied as 5 single-dose ampules per pouch, with prescription only (Rx). The label includes storage, usage instructions, and barcodes, including NDC 68180-984-05.*

FDA Label Image

E986c849 75fc 4c78 B593 1bd0c878adf8 10

Packaging label for Budesonide Inhalation Suspension 0.5 mg/2 mL by Lupin Pharmaceuticals, Inc. The label details the drug as a respiratory inhalation suspension contained in 30 single-dose ampules per carton. Instructions for use are included, along with storage directions and manufacturer information. The NDC code 68180-984-30 is visible, along with a barcode for scanning.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.